| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2015 | WO2015004470A1 Hydroxychloroquine for the treatment of cardiovascular disease |
| 01/15/2015 | WO2015004395A1 Novel salt of 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, preparation thereof and formulations containing same |
| 01/15/2015 | WO2015004371A1 Combination of xenon with an nmda receptor antagonist for fighting a neurodegenerative disease |
| 01/15/2015 | WO2015004347A1 Medication on the basis of xenon, preferably in combination with an nmda receptor antagonist, for fighting the neurogenerative disorder parkinson's disease |
| 01/15/2015 | WO2015004306A1 Oxazolidinone derivatives as ppar ligands |
| 01/15/2015 | WO2015004304A1 Salts of pyridazino[2,3-a]pyrrolo[2,1-c]quinoxaline for the treatment of leishmania infections and diseases that involve the protein tyrosine phosphatase 1b |
| 01/15/2015 | WO2015004243A1 Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation |
| 01/15/2015 | WO2015004240A1 Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption |
| 01/15/2015 | WO2015004216A1 Use of gingival fibroblasts in the treatment of alopecia |
| 01/15/2015 | WO2015004212A1 Inhibitor of neuropilin and use thereof for the treatment of neuropilin-related diseases |
| 01/15/2015 | WO2015004209A1 Inhibitors of adamts4 or adamts5 for use in preventing or treating cardiac remodeling and chronic heart failure |
| 01/15/2015 | WO2015004149A1 Tricyclic pyrrole compounds, their preparation and use in medicaments |
| 01/15/2015 | WO2015004133A1 Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof |
| 01/15/2015 | WO2015004105A1 Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof |
| 01/15/2015 | WO2015004093A1 Dan shen extracts and compounds |
| 01/15/2015 | WO2015004089A1 Losmapimod for use in treating glomerular disease |
| 01/15/2015 | WO2015004075A1 Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones |
| 01/15/2015 | WO2015004041A1 Synthetic vaccines against streptococcus pneumoniae type 1 |
| 01/15/2015 | WO2015004024A1 Substituted pyrazolo-pyridinamines |
| 01/15/2015 | WO2015004007A1 Ethynyl derivatives as metabotropic glutamate receptor antagonists |
| 01/15/2015 | WO2015003958A1 Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways |
| 01/15/2015 | WO2015003723A1 Substituted 4-proline derivatives as iglur antagonists |
| 01/15/2015 | WO2015003662A1 Traditional chinese medicine composition, and preparation and application thereof |
| 01/15/2015 | WO2015003659A1 Traditional chinese medicine composition, and preparation and application thereof |
| 01/15/2015 | WO2015003658A1 Protein tyrosine kinase modulators and methods of use |
| 01/15/2015 | WO2015003641A1 Therapeutically active compounds and their methods of use |
| 01/15/2015 | WO2015003640A1 Therapeutically active compounds and their methods of use |
| 01/15/2015 | WO2015003625A1 Thiazole inner salt compounds and preparation method and use thereof |
| 01/15/2015 | WO2015003623A1 Composition for treating osteoarthritis |
| 01/15/2015 | WO2015003571A1 Novel crystal form of dabrafenib mesylate and preparation method thereof |
| 01/15/2015 | WO2015003536A1 Method for preparing oil-dispersible carotenoid preparation |
| 01/15/2015 | WO2015003479A2 Orally administered solid pellet for infants and children and preparation method therefor |
| 01/15/2015 | WO2015003478A2 Orally disintegrating pill for infants and children and preparation method therefor |
| 01/15/2015 | WO2015003411A1 Combined preparation and use thereof for preparing non-small cell lung cancer drug |
| 01/15/2015 | WO2015003246A1 Combination of a statin with an inflammasome inhibitor |
| 01/15/2015 | WO2015003240A1 Acellular pro-inflammatory compositions, process for making same and methods of using same |
| 01/15/2015 | WO2015003223A1 Heterocyclic compounds and methods of their use |
| 01/15/2015 | WO2014144485A9 Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease |
| 01/15/2015 | WO2014089379A9 Compounds useful as inhibitors of atr kinase |
| 01/15/2015 | WO2013112959A9 Antifibrotic compounds and uses thereof |
| 01/15/2015 | WO2012132022A9 Agent for promoting gene transfer and method of gene transfer using the same |
| 01/15/2015 | US20150018906 Paeoniflorin preparations and uses thereof for fat reduction |
| 01/15/2015 | US20150018782 Transdermal patch |
| 01/15/2015 | US20150018747 Methods and compositions to treat myocardial conditions |
| 01/15/2015 | US20150018552 N-Phenyl-2-pyrimidine-amine Derivatives |
| 01/15/2015 | US20150018516 Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer |
| 01/15/2015 | US20150018428 Lutein/zeaxanthin for glare protection |
| 01/15/2015 | US20150018427 Compounds for treating parvovirus infection |
| 01/15/2015 | US20150018426 Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety |
| 01/15/2015 | US20150018425 Titration package for neramexane and its use in the treatment of an inner ear disorder |
| 01/15/2015 | US20150018424 Process for the preparation of vorinostat |
| 01/15/2015 | US20150018423 Injectable Osteogenic Formula and Method of Using Same |
| 01/15/2015 | US20150018421 Treatment of Sleep Disturbances |
| 01/15/2015 | US20150018420 Method of controlling the release of an active ingredient from a dosage form |
| 01/15/2015 | US20150018419 Tranexamic acid formulations |
| 01/15/2015 | US20150018418 Compositions and methods for prolonging pregnancy |
| 01/15/2015 | US20150018417 Fatty acids as anti-inflammatory agents |
| 01/15/2015 | US20150018416 Aqueous Ophthalmic Composition |
| 01/15/2015 | US20150018415 Therapeutic compositions |
| 01/15/2015 | US20150018412 High throughput fabrication of nanoparticles |
| 01/15/2015 | US20150018406 Modulation of breast cancer growth by modulation of xbp1 activity |
| 01/15/2015 | US20150018400 Treatment of inflammatory bowel disease |
| 01/15/2015 | US20150018398 Methods of using estrogen receptor-beta ligands as radiation mitigators |
| 01/15/2015 | US20150018397 Compositions and methods for treating conditions related to increased eosinophils |
| 01/15/2015 | US20150018395 Chimeric small molecules for the recruitment of antibodies to cancer cells |
| 01/15/2015 | US20150018394 Clevidipine emulsion formulations containing antimicrobial agents |
| 01/15/2015 | US20150018393 Treatment of cancers with acquired resistance to kit inhibitors |
| 01/15/2015 | US20150018391 Animal treatments |
| 01/15/2015 | US20150018390 Methods and compositions for treating post-operative pain comprising a local anesthetic |
| 01/15/2015 | US20150018389 Method for treating parkinsons disease and other neurological diseases |
| 01/15/2015 | US20150018387 High concentration local anesthetic formulations |
| 01/15/2015 | US20150018386 Amorphous form of apixaban, process of preparation and compositions thereof |
| 01/15/2015 | US20150018383 Biomarkers of renal disorders |
| 01/15/2015 | US20150018382 Use of Rupatadine in the Manufacture of Pharmaceutical Composition for Treating Chronic Obstructive Pulmonary Disease |
| 01/15/2015 | US20150018381 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 01/15/2015 | US20150018379 Intranasal Pharmaceutical Dosage Forms Comprising Naloxone |
| 01/15/2015 | US20150018375 Compositions, method, and kits for treating pulmonary conditions |
| 01/15/2015 | US20150018372 Delta opioid receptor agonist compounds |
| 01/15/2015 | US20150018371 Positive allosteric modulators for melanocortin receptors |
| 01/15/2015 | US20150018367 Aurora and flt3 kinases modulators |
| 01/15/2015 | US20150018361 Anti-tumor activity of reduced folates like methylene-tetrahydrofolate |
| 01/15/2015 | US20150018360 Compositions and methods for treating metabolic disorders |
| 01/15/2015 | US20150018358 Compositions and methods for treating purpura |
| 01/15/2015 | US20150018357 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 01/15/2015 | US20150018354 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 01/15/2015 | US20150018353 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators |
| 01/15/2015 | US20150018346 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/15/2015 | US20150018345 Novel neurokinin 1 receptor antagonist compounds |
| 01/15/2015 | US20150018343 Tetraaza-cyclopenta[a]indenyl and their use as Positive Allosteric Modulators |
| 01/15/2015 | US20150018340 Pipecolate-diketoamides for treatment of psychiatric disorders |
| 01/15/2015 | US20150018338 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/15/2015 | US20150018337 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 01/15/2015 | US20150018334 Inhibitors of leukotriene production |
| 01/15/2015 | US20150018333 Inhibitors of leukotriene production |
| 01/15/2015 | US20150018328 Therapeutically active compounds and their methods of use |
| 01/15/2015 | US20150018327 Neuroactive steroid formulations and methods of treating cns disorders |
| 01/15/2015 | US20150018325 Method for late post coital contraception using ulipristal acetate |
| 01/15/2015 | US20150018324 Testosterone undecanoate compositions |
| 01/15/2015 | US20150018323 3b-hydroxysteroid dehydrogenase in steroid-dependent disease |
| 01/15/2015 | US20150018321 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |